Dr Emma Simpson
BSc, PhD
Population Health, School of Medicine and Population Health
Research Fellow
e.l.simpson@sheffield.ac.uk
+44 114 222 0708
+44 114 222 0708
Regent Court (ScHARR)
Full contact details
Dr Emma Simpson
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
91Ö±²¥
S1 4DA
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
91Ö±²¥
S1 4DA
- Profile
-
I am a member of ScHARR-TAG. I have a PhD in psychology, and a background in health services research.
- Research interests
-
Research interests include mental health, arthritis, cardiovascular disease and oncology. I specialise in systematic reviews of clinical effectiveness, with an interest in systematic reviewing methodology.
Current projects
I have recently worked on a number of projects for the Health Technology Assessment Programme, and for the National Institute of Health and Care Excellence. Topics include rheumatoid arthritis, cardiovascular disease and oncology.
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . Discover Psychology, 4.
- . Bone, 130.
- . Health Technology Assessment, 20(35), 1-610.
- . PharmacoEconomics, 33(11), 1187-1194.
- . Health Technol Assess, 18(10), 1-252.
- . Health Technol Assess, 17(36), 1-vi.
- . Br J Surg, 100(9), 1128-1137.
- . Pharmacoeconomics, 31(4), 269-275.
- . Health Technol Assess, 13(17), iii-154.
- . Health Technol Assess, 13(2), iii-91.
- . BMJ, 325(7375), 1265.
All publications
Journal articles
- . Discover Psychology, 4.
- . Health Technology Assessment, 24(29).
- . Bone, 130.
- . International Journal of Technology Assessment in Health Care.
- . PharmacoEconomics, 37(1), 7-18.
- . PharmacoEconomics.
- . PharmacoEconomics, 36, 769-778.
- . Pharmacoeconomics, 36(12), 1427-1437.
- . Health Technology Assessment, 22(20).
- . Health Technology Assessment, 21(71), 1-258.
- . Journal of Rheumatology, 44(7), 973-980.
- . Health Technology Assessment, 20(35), 611-614.
- . PharmacoEconomics, 34(8), 741-750.
- . PharmacoEconomics, 34(7), 673-680.
- . Health Technology Assessment, 20(35), 1-610.
- . PharmacoEconomics, 33(11), 1187-1194.
- . PharmacoEconomics, 33(3), 225-233.
- . Angiology, 65(3), 190-197.
- . Health Technol Assess, 18(10), 1-252.
- . British Journal of Surgery, 100(13), 1838-1839.
- . Health Technol Assess, 17(36), 1-vi.
- . Br J Surg, 100(9), 1128-1137.
- . PharmacoEconomics, 31(6), 471-478.
- . Pharmacoeconomics, 31(4), 269-275.
- . Clinical Oncology, 24(10).
- . Br J Surg, 99(12), 1630-1638.
- . Health Technol Assess, 15(40), 1-210.
- . Journal of Urology, 186(2), 534-535.
- . J Infect, 62(1), 14-25.
- . Health Technol Assess, 14(47), 1-iv.
- . Health Technol Assess, 14 Suppl 1, 63-67.
- A review of discrete event simulation in National Coordinating Centre for Health Technology Assessment-funded work and a case study exploring the cost-effectiveness of testing for thrombophilia in patients presenting with an initial idiopathic venous thromboembolism.. J. Simulation, 4, 14-23.
- . Eur J Cancer, 45(16), 2749-2758.
- . Health Technol Assess, 13(17), iii-154.
- . Health Technol Assess, 13(11), iii-246.
- . Value Health, 12(5), 657-665.
- . Health Technology Assessment, 13, iii-50.
- . Health Technol Assess, 13(5), iii.
- . Health Technol Assess, 13(2), iii-91.
- . Health Technol Assess, 11(26), iii-134.
- . Health Technol Assess, 11(40), 1-144.
- . Psychiatric Bulletin, 30(2), 67-69.
- User and carer involvement in mental health services: from rhetoric to science. BRIT J PSYCHIAT, 183, 89-91.
- . BMJ, 325(7375), 1265.
- A Guide to Involving Users, Ex-users and Carers in Mental Health Service Planning, Delivery or Research: a health technology approach. A Guide to Involving Users, Ex-users and Carers in Mental Health Service Planning, Delivery or Research: A Health Technology Approach.
- .
- .
- . Health Technology Assessment, 14(Suppl 1), 63-67.
- . SN Comprehensive Clinical Medicine.
Chapters
Conference proceedings papers
- The Cost-Effectiveness of Biologic DMARDs in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional DMARDs. ISPOR 17th Annual European Congress, Vol. Value in Health, Vol. 17, Issue 7, A380. Amsterdam, The Netherlands
- The cost-effectiveness of biologic DMARDs in patients with severe or mild-to-severe RA after conventional DMARDs. SMDM (Society for Medical Decision Making) conference 15th Biennial European Meeting. Antwerp, Belgium
- . Value in Health, Vol. 17(7) (pp A380-A380)
- Systematic review and meta-analysis of additional technologies to enhance angioplasty for infra-inguinal peripheral arterial occlusive disease.. HTAi 10th Annual Meeting. Seoul, Korea
- . Value in Health, Vol. 15(7) (pp A633-A633)
- Cost-effectiveness of spinal cord stimulation for chronic pain of neuropathic origin in the UK. IFORS (International Federation of Operational Research Societies Conference). Sandton South Africa
- The clinical effectiveness of oseltamivir, amantadine and zanamivir for the prophylaxis of influenza: A systematic review. Poster M17.4. HTAi 2008. Montreal Canada
- The cost-effectiveness of thrombophilia testing in patients with idiopathic venous thromboembolism. Abstract 3262. 29th Annual Meeting of The Society for Medical Decision Making (SMDM). Pittsburgh, Pennsylvania, USA
Reports
- A Systematic Review of the Efficacy and Clinical Effectiveness of Group Analysis and Analytic/Dynamic Group Psychotherapy
Posters
- PMS4 - RHEUMATOID ARTHRITIS TREATED WITH SIX-MONTHS OF FIRST-LINE BIOLOGIC OR BIOSIMILAR THERAPY: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS.
- Diagnostic accuracy of echocardiography for co-existing pathologies in atrial fibrillation patients: systematic review. HTAi 9th Annual Meeting.
- Ultrasound to Guide Treatment Decisions in Rheumatoid Arthritis.